Health Trials

Diabetes Melletus

2

Review clinical trials related to Diabetes Melletus. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

To find out if taking a drug called infliximab (the "study drug") is safe and effective in reversing insulin dependence in CIADM.

Participants needed: 14
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Jun 23, 2026Locations: 1
Eligibility criteria

New onset diabetes≥ 200 mg/dl and/or A1c ≥6.5 OR [+9]

Participants already on insulin for pre-existing type 1 or type 2 diabetes. [+15]

Read more
Status: Not yet recruiting

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

The purpose of this study is to test the efficacy and safety of orforglipron in participants with T2D (type 2 diabetes) who participate in fasting during Ramadan. For each participant, the study will last up to 48 weeks with a minimum of 7 in clinic visits and 4 virtual visits.

Participants needed: 130
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Eli Lilly and CompanyUpdated: Jun 23, 2026Locations: 37
Eligibility criteria

Have a clinical diagnosis of T2D based on the World Health Organization (WHO) cl... [+4]

Have any form of diabetes other than T2D, including type 1 diabetes (T1D), gesta... [+6]

Read more